Bristol-Myers splits off Mead Johnson, shareholders can swap Bristol shares for Mead stock
Bristol-Myers splits off Mead Johnson Nutrition Pfizer closing some research plants, consolidating others and cutting staff after buying Wyeth more images Enzon Pharma sells specialty drug division to sigma-tau for as much as $327M plus royalties
Covidien says it finished $210M acquisition of brain monitoring technology company Aspect
Covidien closes $210M purchase of Aspect Medical Merck, now the world’s No. 2 drugmaker with Schering-Plough purchase, set for future deals more images Product recalls: cookies, hot chocolate mix, dietary supplements, pain treatment injections
Drugmaker Pfizer closes $68B purchase of Wyeth, gets biotech, vaccine, consumer businessesDrugmaker Pfizer closes $68B acquisition of Wyeth TRENTON, N.J. — Pfizer Inc. and Wyeth have tied the knot in the drug industry’s most expensive marriage this year. Johnson & Johnson makes 4 deals, awaits new product approvals amid slumping salesJ&J wheels and deals, awaits new product approvals NEW BRUNSWICK, N.J. — Johnson & Johnson, the world’s biggest healthcare company and a Dow Jones industrial average component, reports earnings for the third quarter Tuesday morning. Here’s a summary of key developments and analyst opinion related to the period. Kimberly-Clark to purchase health care company I-Flow in deal valued at about $276 millionKimberly-Clark to buy I-Flow in $276M deal DALLAS — Kimberly-Clark Corp. said Friday that it will add higher-margin medical devices to its health care unit by purchasing health care company I-Flow Corp. in a cash deal valued at approximately $276 million excluding acquired cash and cash equivalents. Drugmaker Sanofi-Aventis buys Merck’s half of Merial; step needed for Merck to buy ScheringSanofi buys Merck’s half of animal health business TRENTON, N.J. — French drugmaker Sanofi-Aventis SA has completed its $4 billion purchase of Merck & Co.’s half interest in their veterinary medicine business, Merial Ltd., the companies said Friday. Cardinal Health says holders of debt tendered $1.26B in debt in response to offerCardinal Health says $1.26B debt tendered in offer DUBLIN, Ohio — Health care products and services company Cardinal Health Inc. said Friday that $1.26 billion in debt was tendered in response to the company’s offer last month. Dainippon Sumitomo Pharma of Japan acquiring US drug maker Sepracor for $2.6 billionDainippon of Japan acquires US drug maker Sepracor TOKYO — Japanese drug company Dainippon Sumitomo Pharma Co. is acquiring U.S. drug maker Sepracor Inc. for about $2.6 billion in an effort to expand in the U.S. market, both sides said Thursday. Pfizer paying record $2.3B settlement for illegal promotions of 4 prescription drugsPfizer to pay record $2.3B penalty over promotions WASHINGTON — Pfizer Inc., the world’s largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription drug promotions, the Justice Department announced Wednesday. |
Latest TweetsOwnership Changes
Latest Friend FeedsOwnership Changes
|
